Cargando…
Myxoid liposarcoma: it's a hippo's world
Fused in sarcoma: DNA damage‐inducible transcript 3 protein (FUS:DDIT3) is a chimeric fusion oncoprotein present in 90% of human myxoid liposarcomas (MLS). The study by Trautmann et al in this issue of EMBO Molecular Medicine utilizes a drop‐out RNAi screen to establish hyperactive Yes‐associated pr...
Autores principales: | Regina, Carla, Hettmer, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505570/ https://www.ncbi.nlm.nih.gov/pubmed/30979710 http://dx.doi.org/10.15252/emmm.201910470 |
Ejemplares similares
-
Recurrent myxoid liposarcoma of the hand
por: Boyd, Carter J., et al.
Publicado: (2019) -
Aggressive myxoid liposarcoma of mediastinum.
por: Sharma, B. S., et al.
Publicado: (1992) -
Retroperitoneal perirenal myxoid liposarcoma
por: Crisan, Nicolae, et al.
Publicado: (2015) -
Primary Retroperitoneal Myxoid Liposarcomas
por: Setsu, Nokitaka, et al.
Publicado: (2016) -
Management of myxoid liposarcoma of the extremity
por: Tfayli, Yehia, et al.
Publicado: (2021)